July 22 (Reuters) - CARsgen Therapeutics 2171.HK :
* SEES DECREASE OF NET LOSS FOR SIX MONTHS OF APPROXIMATELY
RMB356 MILLION TO RMB393 MILLION
* SEES NET LOSS OF APPROXIMATELY RMB356 MILLION TO RMB393
MILLION
FOR SIX MONTHS
* SEES ADJUSTED NET LOSS OF APPROXIMATELY RMB334 MILLION TO
RMB370 MILLION FOR SIX MONTHS
* INCREASE IN LOSS DUE TO INCREASED HEAD COUNT, STAFF COST
AND
EXPENSES FOR TESTING AND PRODUCTIONS IN SUPPORT OF CLINICAL
TRIALS
* SEES DECREASE OF NET LOSS AND AN INCREASE OF ADJUSTED NET
LOSS
ON YEAR-ON-YEAR BASIS FOR SIX MONTHS
Further company coverage: 2171.HK
((Reuters.Briefs@thomsonreuters.com;))